Literature DB >> 24998559

Study on the relationship between CXCR4 expression and perineural invasion in pancreatic cancer.

Yu-Mei Jiang1, Guang Li, Bao-Cun Sun, Xiu-Lan Zhao, Zhong-Kai Zhou.   

Abstract

BACKGROUND: Recent reports have shown that C-X-C chemokine receptor 4 (CXCR4) plays an important role in metastasis. Despite a clear understanding of the protein's structure and properties, its functional role remains elusive. We conducted the present study to evaluate the expressions of CXCR4 in pancreatic cancer, and to investigate its relationship with clinicopathological parameters, especially perineural invasion(PNI).
MATERIALS AND METHODS: The association between CXCR4 expression and perineural invasion was determined by immunohistochemistry in pancreatic cancer patients (n=51).
RESULTS: CXCR4 expression was correlated with the existence of PNI and the type of PNI (p=0.042, p=0.040). TIMP-2 expression was also correlated with the existence, the pathway and degree of PNI (p=0.000, p=0.006, p=0.000).
CONCLUSIONS: Our results suggest an association between PNI and expression of CXCR4 and TIMP-2 in pancreatic cancer. CXCR4 may promote the occurrence of PNI in pancreatic cancer cells by decreasing the inhibition of TIMPs on MMP.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24998559     DOI: 10.7314/apjcp.2014.15.12.4893

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  7 in total

1.  Evaluation of the association between perineural invasion and clinical and histopathological features of cervical cancer.

Authors:  You-Sheng Wei; De-Sheng Yao; Ying Long
Journal:  Mol Clin Oncol       Date:  2016-06-24

2.  Mechanisms by which CXCR4/CXCL12 cause metastatic behavior in pancreatic cancer.

Authors:  Jianbo Zhang; Chengxin Liu; Xinkai Mo; Huan Shi; Sheng Li
Journal:  Oncol Lett       Date:  2017-12-05       Impact factor: 2.967

3.  Single-Cell Transcriptomics of Pancreatic Cancer Precursors Demonstrates Epithelial and Microenvironmental Heterogeneity as an Early Event in Neoplastic Progression.

Authors:  Vincent Bernard; Alexander Semaan; Jonathan Huang; F Anthony San Lucas; Feven C Mulu; Bret M Stephens; Paola A Guerrero; Yanqing Huang; Jun Zhao; Nabiollah Kamyabi; Subrata Sen; Paul A Scheet; Cullen M Taniguchi; Michael P Kim; Ching-Wei Tzeng; Matthew H Katz; Aatur D Singhi; Anirban Maitra; Hector A Alvarez
Journal:  Clin Cancer Res       Date:  2018-11-01       Impact factor: 12.531

Review 4.  A meta-analysis for CXCR4 as a prognostic marker and potential drug target in non-small cell lung cancer.

Authors:  Changyuan Zhang; Jie Li; Yi Han; Jian Jiang
Journal:  Drug Des Devel Ther       Date:  2015-06-24       Impact factor: 4.162

5.  CXCR4--A Prognostic and Clinicopathological Biomarker for Pancreatic Ductal Adenocarcinoma: A Meta-Analysis.

Authors:  Andreas Krieg; Jasmin C Riemer; Leila A Telan; Helmut E Gabbert; Wolfram T Knoefel
Journal:  PLoS One       Date:  2015-06-19       Impact factor: 3.240

Review 6.  Molecular Imaging with MRI: Potential Application in Pancreatic Cancer.

Authors:  Chen Chen; Chang Qiang Wu; Tian Wu Chen; Meng Yue Tang; Xiao Ming Zhang
Journal:  Biomed Res Int       Date:  2015-10-22       Impact factor: 3.411

Review 7.  Cellular and molecular mechanisms of perineural invasion of pancreatic ductal adenocarcinoma.

Authors:  Jingbo Li; Rui Kang; Daolin Tang
Journal:  Cancer Commun (Lond)       Date:  2021-07-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.